DONGGUAN FUTONG TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

DONGGUAN FUTONG TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include XECIFOIN. The owner is based in DONGGUAN CITY, GUANGDONG PROVINCE.

ROOM 301, BUILDING 1, NO. 5, SOUTH

DONGGUAN CITY, GUANGDONG PROVINCE 523660 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

XECIFOIN
XECIFOIN
Registered 2020

Trademark Classifications

DONGGUAN FUTONG TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does DONGGUAN FUTONG TECHNOLOGY CO., LTD. have?

DONGGUAN FUTONG TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does DONGGUAN FUTONG TECHNOLOGY CO., LTD. file in?

DONGGUAN FUTONG TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are DONGGUAN FUTONG TECHNOLOGY CO., LTD.'s most well-known trademarks?

DONGGUAN FUTONG TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as XECIFOIN. These are among 1 currently registered trademark in the portfolio.

What is DONGGUAN FUTONG TECHNOLOGY CO., LTD.'s trademark registration success rate?

DONGGUAN FUTONG TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.